Lawrence Klein - Jan 22, 2025 Form 4 Insider Report for Oruka Therapeutics, Inc. (ORKA)

Role
Chief Executive Officer, Director
Signature
/s/ Paul Quinlan, as attorney-in-fact for Lawrence Klein
Stock symbol
ORKA
Transactions as of
Jan 22, 2025
Transactions value $
$0
Form type
4
Date filed
1/24/2025, 04:41 PM
Previous filing
Sep 6, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ORKA Employee Stock Option (right to buy) Award $0 +230K $0.00 230K Jan 22, 2025 Common Stock 230K $12.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 1/48 of the underlying shares monthly from January 1, 2025.